A Retrospective Chart Review of Central Centrifugal Cicatricial Alopecia Patients at a Single Urban Institution

    August 2023 in “ JAAD international ”
    Eliza Balazic, Anna Chen, Hailey Konisky, Kelly Hawkins, Janet S. Choi, Nour Mhaimeed, Chesahna Kindred, Kseniya Kobets
    Image of study
    TLDR Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.
    This retrospective chart review at Montefiore Medical Center analyzed 185 female patients diagnosed with central centrifugal cicatricial alopecia (CCCA) from July 2015 to March 2022. The study found that 82.7% of patients identified as Black or African American, with a mean age of 53.3 years at presentation. Hair loss at the vertex or crown was the most common symptom, reported by 79.5% of patients. Treatment was administered to 85.9% of patients, with topical medications being the most common. The study highlights the need for a unique ICD-10 code for CCCA to facilitate larger epidemiologic studies and better understand the disease's demographics and characteristics.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 59 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

      community Exploring Bryan Johnson's Hair Routine In Detail

      in Research/Science  64 upvotes 11 months ago
      Bryan Johnson uses a custom hair loss treatment that includes topical finasteride, minoxidil, azelaic acid, diclofenac, tea tree oil, rosemary oil, ginkgo biloba, biotin, and melatonin, which have shown varying degrees of effectiveness with minimal side effects. He also undergoes PRP and laser therapy, and has tried dutasteride mesotherapy.

    Similar Research

    5 / 1000+ results
      Central Centrifugal Cicatricial Alopecia

      research Central Centrifugal Cicatricial Alopecia

      72 citations, July 2008 in “Dermatologic Therapy”
      CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.
      Clinical Trials and Hair Loss

      research Clinical Trials and Hair Loss

      1 citations, July 2018 in “Elsevier eBooks”
      Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.